Perceptive Advisors LLC
- SEC CIK
- 0001224962
- Latest filing
- Aug 14, 2026
Holdings in Q2 2025
Holdings as of Jun 30, 2025, filed Aug 14, 2025. Long positions only; changes compare share counts with Q1 2025.
- Positions
- 82
- −4 vs. Q1 2025
- Portfolio value
- $2.67B
- −$154.7M (−5.5%) vs. Q1 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| VRNAVerona Pharma plc | SPONSORED ADS | 5,507,591 | $520.9M | 19.5% | −1,055,749−16.1% | Reduced | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 963,886 | $166.4M | 6.2% | +963,886 | New | History |
| ACLXArcellx, Inc. | COMMON STOCK | 2,478,000 | $163.2M | 6.1% | −448,478−15.3% | Reduced | History |
| RYTMRhythm Pharmaceuticals, Inc. | COM | 2,418,299 | $152.8M | 5.7% | −130,146−5.1% | Reduced | History |
| NUVLNuvalent, Inc. | COM | 1,375,180 | $104.9M | 3.9% | −258,788−15.8% | Reduced | History |
| AORTArtivion, Inc. | COM | 2,793,703 | $86.9M | 3.3% | 00.0% | Unchanged | History |
| MGTXMeiraGTx Holdings plc | COM | 12,626,103 | $82.2M | 3.1% | +45,000+0.4% | Added | History |
| INSMINSMED Inc | COM PAR $.01 | 650,252 | $65.4M | 2.5% | +140,952+27.7% | Added | History |
| EWTXEdgewise Therapeutics, Inc. | COM | 4,639,949 | $60.8M | 2.3% | −1,907,379−29.1% | Reduced | History |
| PTGXProtagonist Therapeutics, Inc | COM | 1,074,448 | $59.4M | 2.2% | −16,823−1.5% | Reduced | History |
| SLDBSolid Biosciences Inc. | COM NEW | 11,906,646 | $58.0M | 2.2% | 00.0% | Unchanged | History |
| APGEApogee Therapeutics, Inc. | COM | 1,182,148 | $51.3M | 1.9% | +59,381+5.3% | Added | History |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 7,902,365 | $50.7M | 1.9% | +28,017+0.4% | Added | History |
| IMTXImmatics N.V. | SHS | 9,383,456 | $50.5M | 1.9% | 00.0% | Unchanged | History |
| AKROAkero Therapeutics, Inc. | COM | 915,887 | $48.9M | 1.8% | +122,927+15.5% | Added | History |
| OMDAOmada Health, Inc. | COM | 2,426,330 | $44.4M | 1.7% | +2,426,330 | New | History |
| FOLDAmicus Therapeutics, Inc. | COM | 7,412,830 | $42.5M | 1.6% | −14,051,697−65.5% | Reduced | History |
| ROIVRoivant Sciences Ltd. | SHS | 3,331,465 | $37.5M | 1.4% | +3,331,465 | New | History |
| MRUSMerus N.V. | COM | 708,176 | $37.3M | 1.4% | +17,691+2.6% | Added | History |
| SLNOSoleno Therapeutics Inc | COM | 430,439 | $36.1M | 1.4% | −1,076,163−71.4% | Reduced | History |
| ATXSAstria Therapeutics, Inc. | COM | 6,485,420 | $34.8M | 1.3% | 00.0% | Unchanged | History |
| IMVTImmunovant, Inc. | COM | 2,137,890 | $34.2M | 1.3% | −706,182−24.8% | Reduced | History |
| NBIXNeurocrine Biosciences Inc | Stock | 255,050 | $32.1M | 1.2% | +155,000+154.9% | Added | History |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 752,921 | $31.7M | 1.2% | −227,973−23.2% | Reduced | History |
| BSXBoston Scientific Corp | Stock | 280,000 | $30.1M | 1.1% | +150,000+115.4% | Added | History |
| CAICaris Life Sciences, Inc. | COM | 1,098,163 | $29.3M | 1.1% | +1,098,163 | New | History |
| ISRGIntuitive Surgical Inc | COM NEW | 45,119 | $24.5M | 0.9% | +4,500+11.1% | Added | History |
| ADMAAdma Biologics, Inc. | COM | 1,303,468 | $23.7M | 0.9% | −69,765−5.1% | Reduced | History |
| BBNXBeta Bionics, Inc. | COM | 1,593,608 | $23.2M | 0.9% | 00.0% | Unchanged | History |
| SYRESpyre Therapeutics, Inc. | COM NEW | 1,529,445 | $22.9M | 0.9% | −783,827−33.9% | Reduced | History |
| EOLSEvolus, Inc. | COM | 2,474,843 | $22.8M | 0.9% | −1,654,299−40.1% | Reduced | History |
| CELCCelcuity Inc. | COM | 1,633,208 | $21.8M | 0.8% | −729,071−30.9% | Reduced | History |
| DYNDyne Therapeutics, Inc. | COM | 2,247,390 | $21.4M | 0.8% | −66,013−2.9% | Reduced | History |
| SIONSionna Therapeutics, Inc. | COM | 1,216,045 | $21.1M | 0.8% | −35,056−2.8% | Reduced | History |
| AXSMAxsome Therapeutics, Inc. | COM | 198,534 | $20.7M | 0.8% | −156,573−44.1% | Reduced | History |
| RGENRepligen Corp | COM | 166,000 | $20.6M | 0.8% | +36,199+27.9% | Added | History |
| PODDInsulet Corp | Stock | 60,387 | $19.0M | 0.7% | −11,210−15.7% | Reduced | History |
| OMOutset Medical, Inc. | COM NEW | 833,333 | $16.0M | 0.6% | 00.0% | Unchanged | History |
| ZYMEZymeworks Inc. | COM | 1,275,274 | $16.0M | 0.6% | −589,398−31.6% | Reduced | History |
| CTMXCytomX Therapeutics, Inc. | COM | 6,993,646 | $15.9M | 0.6% | +6,993,646 | New | History |
| ALDXAldeyra Therapeutics, Inc. | COM | 4,051,631 | $15.5M | 0.6% | −5,224,220−56.3% | Reduced | History |
| CRLCharles River Laboratories International, Inc. | COM | 100,000 | $15.2M | 0.6% | +100,000 | New | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 1,146,935 | $15.1M | 0.6% | −1,893,460−62.3% | Reduced | History |
| INBXInhibrx Biosciences, Inc. | COM | 977,892 | $14.0M | 0.5% | −86,134−8.1% | Reduced | History |
| ADGMAdagio Medical Holdings, Inc. | COM | 9,876,576 | $12.8M | 0.5% | +64,157+0.7% | Added | History |
| NRIXNurix Therapeutics, Inc. | COM | 1,096,985 | $12.5M | 0.5% | +799,432+268.7% | Added | History |
| TVTXTravere Therapeutics, Inc. | COM | 834,252 | $12.3M | 0.5% | +834,252 | New | History |
| OBIOOrchestra BioMed Holdings, Inc. | COM | 4,592,556 | $12.3M | 0.5% | 00.0% | Unchanged | History |
| DRUGBright Minds Biosciences Inc. | COM NEW | 420,690 | $11.0M | 0.4% | −23,959−5.4% | Reduced | History |
| IKTInhibikase Therapeutics, Inc. | COM NEW | 5,432,293 | $10.6M | 0.4% | −492,707−8.3% | Reduced | History |
| VKTXViking Therapeutics, Inc. | COM | 380,700 | $10.1M | 0.4% | −128,305−25.2% | Reduced | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 270,000 | $9.82M | 0.4% | +270,000 | New | History |
| KYMRKymera Therapeutics, Inc. | COM | 210,106 | $9.17M | 0.3% | +210,106 | New | History |
| NAUTNautilus Biotechnology, Inc. | COM | 12,594,211 | $9.13M | 0.3% | 00.0% | Unchanged | History |
| PENPenumbra Inc | COM | 32,797 | $8.42M | 0.3% | +32,797 | New | History |
| CBIOCrescent Biopharma, Inc. | COM | 453,686 | $7.32M | 0.3% | +453,686 | New | History |
| AQSTAquestive Therapeutics, Inc. | COM | 2,190,420 | $7.25M | 0.3% | −1,536,788−41.2% | Reduced | History |
| JANXJanux Therapeutics, Inc. | COM | 292,686 | $6.76M | 0.3% | −677,726−69.8% | Reduced | History |
| AVRAnteris Technologies Global Corp. | COM | 1,705,130 | $6.46M | 0.2% | −434,870−20.3% | Reduced | History |
| XENEXenon Pharmaceuticals Inc. | COM | 200,791 | $6.28M | 0.2% | −124,533−38.3% | Reduced | History |
| VRDNViridian Therapeutics, Inc. | COM | 447,507 | $6.26M | 0.2% | −212,155−32.2% | Reduced | History |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 1,438,595 | $5.75M | 0.2% | +1,438,595 | New | History |
| SEPNSepterna, Inc. | COM | 541,450 | $5.72M | 0.2% | +541,450 | New | History |
| GMEDGlobus Medical Inc | Stock | 88,500 | $5.22M | 0.2% | +88,500 | New | History |
| NVNOenVVeno Medical Corp | COMMON STOCK | 1,284,966 | $5.13M | 0.2% | +1,284,966 | New | History |
| BBOTBridgeBio Oncology Therapeutics, Inc. | CL A ORD SHS | 398,000 | $4.23M | 0.2% | 00.0% | Unchanged | History |
| IRDOpus Genetics, Inc. | COM | 4,325,000 | $4.07M | 0.2% | 00.0% | Unchanged | History |
| CTNMContineum Therapeutics, Inc. | CL A | 699,486 | $2.78M | 0.1% | −741,763−51.5% | Reduced | History |
| LYRALyra Therapeutics, Inc. | COM NEW | 255,150 | $2.29M | 0.1% | 00.0% | UnchangedConverted for a 1-for-50 split | History |
| SCPHscPharmaceuticals Inc. | COM | 500,000 | $1.91M | 0.1% | 00.0% | Unchanged | History |
| LONALeonaBio, Inc. | COM | 5,402,964 | $1.63M | 0.1% | 00.0% | Unchanged | History |
| RAPTRAPT Therapeutics, Inc. | COM NEW | 183,890 | $1.47M | 0.1% | +183,890 | New | History |
| TRIBTrinity Biotech PLC | SPONS ADR NEW | 1,790,000 | $1.16M | <0.1% | +1,790,000 | New | History |
| FBRXForte Biosciences, Inc. | COM NEW | 68,192 | $881.7K | <0.1% | +68,192 | New | History |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 139,667 | $696.9K | <0.1% | −380,333−73.1% | Reduced | History |
| BDSXBiodesix Inc | COM | 2,173,880 | $613.0K | <0.1% | 00.0% | Unchanged | History |
| LXEOLexeo Therapeutics, Inc. | COM | 139,835 | $562.1K | <0.1% | 00.0% | Unchanged | History |
| APYXApyx Medical Corp | COM | 150,000 | $337.5K | <0.1% | 00.0% | Unchanged | History |
| KALAKALA BIO, Inc. | COMM STK | 55,227 | $262.9K | <0.1% | −222,383−80.1% | Reduced | History |
| ENSCEnsysce Biosciences, Inc. | COM NEW | 86,666 | $193.3K | <0.1% | 00.0% | Unchanged | History |
| RVMDWRevolution Medicines, Inc. | *W EXP 12/17/202 | 250,000 | $65.7K | <0.1% | 00.0% | Unchanged | History |
| Surrozen, Inc.86889P117 | *W EXP 08/01/203 | 166,666 | $3.02K | <0.1% | 00.0% | Unchanged | – |
Options (2)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $24.9M | – |
| CAPRCapricor Therapeutics, Inc. | COM NEW | $6.45M | $993.0K |
Sold out since Q1 2025 (22)
Positions held at the end of Q1 2025 that are gone from this filing.
| Security | Class | Shares in Q1 2025 | Value in Q1 2025 | % of portfolio in Q1 2025 | History |
|---|---|---|---|---|---|
| ITCIIntra-Cellular Therapies, Inc. | COM | 786,358 | $103.7M | 3.7% | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 12,711,788 | $42.3M | 1.5% | History |
| ARGXArgenx SE | SPONSORED ADR | 59,510 | $35.2M | 1.2% | History |
| PCVXVaxcyte, Inc. | COM | 706,567 | $26.7M | 0.9% | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 46,500 | $15.4M | 0.5% | History |
| DXCMDexcom Inc | COM | 178,000 | $12.2M | 0.4% | History |
| ACRVAcrivon Therapeutics, Inc. | COMMON STOCK | 5,360,858 | $10.9M | 0.4% | History |
| CRGXCARGO Therapeutics, Inc. | COM | 2,431,085 | $9.89M | 0.4% | History |
| EYPTEyePoint, Inc. | COM NEW | 1,537,274 | $8.33M | 0.3% | History |
| IRONDisc Medicine, Inc. | COM | 150,000 | $7.45M | 0.3% | History |
| ADPTAdaptive Biotechnologies Corp | COM | 930,972 | $6.92M | 0.2% | History |
| OCULOcular Therapeutix, Inc | COM | 915,775 | $6.71M | 0.2% | History |
| DCTHDelcath Systems, Inc. | COM NEW | 462,422 | $5.89M | 0.2% | History |
| RAPTRAPT Therapeutics, Inc. | COM | 4,418,947 | $5.39M | 0.2% | History |
| KMTSKestra Medical Technologies, Ltd. | SHS | 200,000 | $4.98M | 0.2% | History |
| OKUROnKure Therapeutics, Inc. | COM CL A | 1,004,439 | $4.32M | 0.2% | History |
| MREOMereo BioPharma Group plc | SPON ADS | 876,961 | $1.97M | 0.1% | History |
| TRAWTraws Pharma, Inc. | COM NEW | 421,781 | $970.1K | <0.1% | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 140,726 | $938.6K | <0.1% | History |
| CGEMCullinan Therapeutics, Inc. | COM | 80,100 | $606.4K | <0.1% | History |
| APLTApplied Therapeutics, Inc. | COM | 860,000 | $420.5K | <0.1% | History |
| NBTXNanobiotix S.A. | SPONSORED ADS | 105,053 | $376.1K | <0.1% | History |